Bøger udgivet af American Psychiatric Association Publishing

Drawing from their pioneering work on infant-parent mental health, the editors of Infant and Early Childhood Mental Health: Core Concepts and Clinical Practice have assembled a comprehensive, clinically useful volume for health care providers who serve children and families from pregnancy through age 5 in their practices.

Authoritative, comprehensive, and cutting-edge, the Handbook of Mentalizing in Mental Health Practice is the single most important resource for clinicians and trainees learning about-and incorporating-MBT into their therapeutic repertoire.

What if how medication was prescribed was as important as what was prescribed? This is the central tenet of Psychodynamic Psychopharmacology, a new guide that emphasizes integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance and optimize treatment outcomes with difficult-to-treat patients.

This text examines every aspect of the disorder in an up-to-date, rigorous, and clinically oriented manner. The editors address the disease in a systematic, accessible way, identifying the challenges of diagnosis and treatment.

This guide is both compatible with the DSM-5 Section III Alternative Model for Personality Disorders and elaborates on it, offering clinicians at all levels of experience an accessible framework to guide evaluation and treatment of personality disorders.

The SCID-5-PD is the updated version of the former Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). The SCID-5-PD name reflects the elimination of the multiaxial system in DSM-5.

This updated, second edition also features ways to employ CBT to reduce suicide risk and tips on integrating therapies related to CBT -- including dialectical behavior therapy, mindfulness-based cognitive therapy, and well-being therapy.

This is not a general text, then, but one focused on building competence and confidence in trauma-centered interventions, providing methods that should be readily and widely applicable to clinical practice.

Chapters on assessment and treatment, along with accompanying videos, offer comprehensive, state-of-the-art coverage that will benefit clinicians in practice, such as psychiatrists and psychotherapists, as well as mental health trainees.

By summarizing the empirical studies, proposing a universal language of defense mechanisms, and demonstrating how various assessment methods can be used in diagnosis, case formulation, and treatment, Dr. Vaillant and an interdisciplinary group of contributors provide the groundwork for clinical practice as well as future research in the field.

This practical and insightful guide distills into one volume CBT techniques for individual therapy and video demonstrations on DVD that illustrate how these techniques can be used to tackle a wide range of severe clinical problems.

This book offers practical guidance for assessing the amenability of patients to psychotherapy. By focusing on which patients are likely to respond well to therapeutic intervention and which will prove most resistive, the book can assist clinicians in determining with what kinds of patients will most likely succeed.

"Transcranial magnetic stimulation (TMS) is a noninvasive method to stimulate the human brain, modulating brain activity without surgery or anesthesia. TMS uses a brief, high-intensity, pulsed magnetic field, which induces an electrical field capable of depolarizing a localized brain area. In October 2008, the first TMS system was cleared by the FDA to treat adult patients with major depressive disorder (MDD) who have not responded to one antidepressant medication. Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice, 2nd Edition, is a practical reference for managing patients who are candidates for TMS. Since publication of the first edition, devices have received FDA clearance for obsessive-compulsive disorder, anxiety comorbid with MDD, and smoking cessation, and insurance coverage for TMS has expanded. The book discusses the integration of TMS with psychotherapy, pharmacotherapy, and other forms of neuromodulation; the identification of appropriate patients for referral to a TMS clinician; coordination of care to ensure the best outcomes during the acute, continuation, and maintenance treatment phases of depression; and the evolving nature of TMS research. The volume appendix lists various options for advanced TMS training"--

"There is a side of cannabis use that is not advertised or promoted, a physically and psychiatrically detrimental side, which might be darker than most of us realize. The ever-increasing use of cannabis across the United States is least partially due to its legalization. Evidence of the impact of cannabis on mental health should raise more concerns among mental health professionals, legislators, and the public; we are facing a serious and growing problem that requires efforts similar to those developed during the antitobacco campaign of recent decades. As both legalization of cannabis and a rise of illegal cannabis production continues, physicians need to be aware of the potential harms of cannabis on both physical and mental health. Without a true and comprehensive understanding of the deleterious impact of cannabis use, we will not be able to effectively educate our patients, the public, and policy makers to mitigate the risks associated with use. This volume collects information related to the risk of cannabis use on the human body from authors from different corners of the world"--

"Since the invention of the cigarette-making machine towards the end of the nineteenth century and then throughout the twentieth century, cigarettes have been by far the most common form of nicotine consumption in the United States, with cigars and oral tobacco (chew and snuff) trailing far behind. Despite declines in smoking, it remains the number one cause of preventable death in the United States. It has been estimated that tobacco smoking causes over 400,000 premature deaths per year in the United States and 4.9 million deaths per year worldwide (8.8% of all global deaths). Since only the beginning of the twenty-first century has the tobacco industry acknowledged the scientific consensus on the addictiveness and other health effects of cigarettes and has diversified into marketing a range of other products. The 1964 U.S. Surgeon General's report on tobacco and health concluded that cigarettes are a cause of lung cancer, and numerous follow-up reports clarified the enormous harmfulness of cigarette smoking. This book describes the harms to health from smoking cigarettes and other tobacco products, the relative harms from non-smoked nicotine products, the neurobiology of tobacco/nicotine dependence and addiction, comorbidities of tobacco addiction with other behavioral health conditions, and ways to address tobacco/nicotine use in the clinical setting and engage patients in treatment"--

"Overrepresentation of people with serious mental illness (SMI) occurs at every level of the criminal legal system. More than 30% of those with SMI have lifetime histories of arrest. Most of these arrests are for minor offenses, and this population is overrepresented in survival-type crimes associated with poverty and homelessness. Among the jail population, prevalence rates of having a current SMI are several times higher than those of the general population; individuals with SMI are also overrepresented among probationers and parolees. Once arrested, people with SMI are at higher risk of re-arrest; serve more days in pretrial detention; if convicted, serve more of their jail or prison sentences; and are more likely to have their probation or parole revoked than are offenders without SMI. Hence, once arrested, they become entangled. The editors of this book designed a study of the most frequent and overrepresented misdemeanor charges among people with SMI in four cities: Atlanta/Fulton County, GA; Chicago/Cook County, IL; the borough of Manhattan, New York City, NY; and Philadelphia, PA. The study objectives were to 1 identify the misdemeanor charges most overrepresented among individuals with SMI; 2 understand those charges in various contexts by conducting systems mapping exercises in four cities; 3 conduct focus groups; and 4 explain the use of misdemeanor charges among people with SMI as a foundation for further research, as well as policy and program development. The authors focused on specific misdemeanor charges such as criminal trespass, shoplifting, obstruction, and minor assault, as well as variations, which might include loitering, vagrancy, petit larceny, resisting arrest, disorderly conduct, and the like (and additional charges such as failure to appear to court and probation violation). These charges set the stage for the criminalization of serious mental illness. The book reviews reforms and policy advances in recent years in terms of alternatives to incarceration and diversion programs, attempts to imbue the criminal legal system with a rehabilitative ethos, and policies designed to reduce the footprint of the misdemeanor criminal legal system altogether. The authors emphasize the need for multisystem collaboration with a specific focus on advancing, and ensuring, racial equity in all reforms"--

This guide is designed to help clinical learners, teachers, and practitioners in psychiatry, psychology, and social work understand and apply diagnostic criteria. An introduction to diagnostic frameworks and how they shape work with patients is followed by chapters focusing on DSM-5-TR's diagnostic categories.

"Psychodermatology, also referred to as psychocutaneous medicine, lies at the intersection of two medical specialties: psychiatry and dermatology. A primarily psychiatric condition can present with dermatologic symptoms, and many dermatologic conditions have profound psychological impacts. In Clinical Psychodermatology: From Diagnosis to Therapy, the compiled case reports have been organized into central themes: general principles (chapters 1-3), psychosis-spectrum disorders (chapters 4 and 11), impulse control disorders (chapters 5, 6, 7, and 9), and anxiety- and mood-associated disorders (chapters 8, 10, 11, and 12). Treatment often warrants both pharmacological and psychological intervention, and a multidisciplinary approach is the most successful. Collaboration between dermatologists, psychologists, psychiatrists, and social services leads to higher patient satisfaction and improved outcomes. Unfortunately, the bias against mental illness serves as a barrier. To alleviate distress and optimize functioning, a mental health clinician familiar with addressing these conditions is ideal, and in areas where such specialists are scarce, an empathic therapist is likely to be worthwhile"--

"The goal of this guideline is to improve the quality of care and treatment outcomes for patients with borderline personality disorder (BPD) as defined in Section II of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision. Since publication of the last American Psychiatric Association (APA) practice guideline, there have been many studies on psychotherapies for individuals with BPD as well as some studies on pharmacotherapies. Despite this, there are still misconceptions about BPD and substantial gaps in the availability of evidence-based treatments for individuals with BPD. This practice guideline aims to help clinicians improve the care and well-being of their patients by reviewing current evidence and providing evidence-based statements that are intended to enhance knowledge and optimize treatment of BPD"--

"Borderline personality disorder (BPD) and alcohol use disorder (AUD) co-occur quite often. Nearly half of all patients meeting diagnostic criteria for BPD have a concurrent AUD, and more than half will have AUD sometime in their life. Yet no integrated treatments for this common set of conditions have been adequately tested or disseminated. While still among the most stigmatized disorders in psychiatry and medicine at large, BPD's prognosis has been radically transformed; despite the longstanding belief that it was not treatable, we now know that it is highly likely to remit over time and is responsive to numerous evidence-based psychotherapies. Alcohol use combines with the vulnerabilities of BPD bidirectionally to compound disabling symptoms, increase risk for death by suicide, and render treatment more challenging. But, like BPD, AUD is treatable. These facts about BPD and AUD make obvious the need for combined intervention. Good Psychiatric Management for Borderline Personality Disorder and Alcohol Use Disorder provides education and a general approach to clinical management. Good psychiatric management's (GPM's) multimodal approach naturally incorporates medication, individual therapies, clinical case management, family work, and mutual help groups. BPD and AUD share core features of diminished neurocognitive and emotional processing capacity and insufficient agency, self-esteem, and coherent sense of self, and they are both associated with diminished social networks. Multimodal treatment broadens social networks (multiple clinical professionals providing care alongside loved ones) to reduce risk factors for relapse, increase support, and enhance recovery from both disorders. Treatment emphasizes the development of different coping responses and more effective prosocial behaviors that are more likely to generate the interpersonal responses needed to build health in sense of self and relationships. GPM uses motivational interviewing that focuses on drinking behaviors as well as self-destructive behaviors related to BPD. This generalist intervention is meant to be "good enough," in the spirit of pediatrician and psychoanalyst Donald Winnicott discussing normal developmental transformations. GPM encourages clinicians to gradually foster tolerable challenges for patients in their lives outside of treatment so that they can develop a sense of capability to manage those challenges on their own"--

Engaging case studies drawn from the real-world practice of a diverse group of experts bring DSM-5-TR to life in this exhaustive new volume. Designed to familiarize undergraduate, graduate, and postgraduate students in psychology, psychiatry, social work, counseling, and psychiatric nursing with the diagnosis of psychopathology, this guide is equally useful for experienced clinicians seeking to improve their understanding of the new concepts and terminology in DSM-5-TR. Organized according to the order of the 19 diagnostic groupings as they appear in DSM-5-TR, this book includes at least one case for each mental disorder listed in DSM-5-TR. In each richly detailed chapter, readers will find:An overview of the manifestation of the various diagnoses in the corresponding disorder class. A table summarizing key characteristics of each individual disorder. Comprehensive sections on the individual diagnoses that describe hallmark features, prevalence data, clinical course, and common comorbidities, among other topics. Where specific factors-including severity, course, and symptom presentation-affect the manifestation of a disorder, the book includes multiple cases that illustrate that diagnostic heterogeneity. Unique to this edition are four new, cutting-edge cases: two that are included in the Conditions for Further Study section in DSM-5-TR and an additional two included in the current edition of the World Health Organization's International Classification of Diseases, 11th revision. The book concludes with an alphabetical index of case names and a comprehensive index of diagnoses with their related cases for ease of reference. Unmatched in its scope and detail, Learning DSM-5-TR by Case Example is an essential resource for all those looking to translate the latest diagnostic criteria to real world practice.

"Rethinking Social Anxiety provides a summary of what has been learned from research about social anxiety and offers case examples of teens and adults with persistent fears and shame related to what others might think of them. It describes their avoidance in seeking help and details a variety of treatment options with psychotherapy, medications, and/or family interventions"--

"The DSM-5-TRª Pocket Guide for Child and Adolescent Mental Health teaches readers how to formulate a diagnosis and treatment plan for this patient population. This revision builds on the successful first edition by adding the relevant updates to DSM-5-TR and addressing the changing patterns of seeking mental health care"--

"This text demonstrates the influence that social media has in all aspects of young lives and summarizes the latest research findings on more than a dozen different aspects of social media as they relate to youth mental health. It is divided into two sections: Part 1 examines youth and social media use through multiple lenses of adolescent development, and Part 2 considers social media's clinical applications and implications for youth. The goal is to provide a comprehensive look at the impact of social media on the mental health of young people today and a foundational framework from which mental health professionals, policymakers, industry leaders, and researchers can consider a renewed phase of innovation that puts youth health and well-being at the forefront"--

Nature Therapy makes a compelling case for nature-based treatments, including history, recommendations, and definitions, and offers a way in to remembering what the mental health field has forgotten: how nature can augment traditional medical treatments to restore, heal, and even prevent potential illness.

"Ketamine was synthesized in 1962 after Parke-Davis scientists had discovered PCP, realized its potential and also its dangerous qualities, and returned to the lab to find a cousin with fewer drawbacks. Rasmussen traces ketamine's story from the lab to the anesthesia practice, describing the molecule and how it works in the body. Ketamine-again following PCP-became a commonly used recreational drug and is a problem substance in Asia, where it is easy to obtain. As an anesthetic, ketamine is highly effective, but it has shown odd characteristics such as dissociative states, mystical experiences, feelings that mimic near-death experiences, euphoria, and other symptoms akin to psychedelia. A serious side effect with prolonged use is a highly debilitating condition called ulcerative cystitis. Ketamine has been studied as an analog for schizophrenia, to try to find causes and treatments for that disorder. In recent times, ketamine is being explored as a treatment for chronic pain, depression, substance use disorders, and psychotherapy augmentation. Rasmussen concludes the book with a discussion of ketamine's paradoxical effects: is it a neuroprotectant or a neurotoxin?"--